Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 202.63% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 202.63% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 202.63% | -- | |||
| SG&A Expenses | 20.98% | -4.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.42% | 18.32% | |||
| Operating Income | 19.75% | -18.15% | |||
| Income Before Tax | 20.14% | -7.80% | |||
| Income Tax Expenses | -65.28% | 172.67% | |||
| Earnings from Continuing Operations | 21.72% | -18.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -22.01% | 17.55% | |||
| Net Income | 21.36% | -18.81% | |||
| EBIT | 19.75% | -18.15% | |||
| EBITDA | 20.42% | -18.58% | |||
| EPS Basic | 21.87% | -16.98% | |||
| Normalized Basic EPS | -3.77% | -205.77% | |||
| EPS Diluted | 21.87% | -16.98% | |||
| Normalized Diluted EPS | -3.77% | -205.77% | |||
| Average Basic Shares Outstanding | 0.60% | 1.61% | |||
| Average Diluted Shares Outstanding | 0.60% | 1.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||